HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 290/6/G1211    most recent 00078.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Khomenko, T. Articles by Chen, L. Search for Related Content PubMed PubMed Citation Articles by Khomenko, T. Articles by Chen, L.

MUCOSAL BIOLOGY

Suppression of early growth response factor-1 with egr-1 antisense oligodeoxynucleotide aggravates experimental duodenal ulcers

Diagnostic and Molecular Medicine Health Care Group, Veterans Affairs Medical Center, and Departments of Pathology and Pharmacology, University of California-Irvine, Long Beach, California

Submitted 21 February 2005 ; accepted in final form 9 February 2006

Previously, we demonstrated that cysteamine releases endothelin-1 in the rat duodenal mucosa, followed by increased expression of early growth response factor-1 (egr-1). We hypothesized that egr-1 is a key mediator gene in the multifactorial mechanisms of duodenal ulcer development and healing because its protein, transcription factor product Egr-1, regulates the expression of angiogenic growth factors. We wanted to determine the effect of egr-1 antisense oligonucleotide on cysteamine-induced duodenal ulcers as well as on the expression of bFGF, PDGF, and VEGF, of which synthesis is modulated by Egr-1. An antisense oligonucleotide to egr-1 was used to inhibit the synthesis of Egr-1 and to determine its effect on ulcer formation in the rat model of cysteamine-induced duodenal ulceration. Real-time RT-PCR and Western blot analysis were used to assess the expression of Egr-1 mRNA and protein as well as ERK, bFGF, PDGF, and VEGF. The antisense Egr-1 oligonucleotide inhibited the expression of egr-1 mRNA and protein and increased the duodenal ulcer size from 8.1 ± 1.8 mm² in controls to 20.7 ± 4.0 mm² (P < 0.01). Cysteamine induced phosphorylation of ERK1/2 and enhanced the synthesis of bFGF, PDGF, and VEGF in the preulcerogenic stages of duodenal ulceration, whereas egr-1 antisense oligonucleotide markedly decreased the expression of these growth factors in the duodenal mucosa. We also demonstrated that Egr-1 expression relates to the ulcerogenic effect of cysteamine because these actions were not exerted by the toxic analog ethanolamine. Thus Egr-1 seems to play a critical role in duodenal ulceration because Egr-1 downregulation aggravates experimental duodenal ulcers, most likely through the transcriptional inhibition of bFGF, PDGF, and VEGF synthesis.

early growth response factor-1; cysteamine-induced duodenal ulcer; transcription regulation; angiogenic growth factors

This article has been cited by other articles:

				T. Khomenko, S. Szabo, X. Deng, H. Ishikawa, G. J. Anderson, and G. D. McLaren Role of iron in the pathogenesis of cysteamine-induced duodenal ulceration in rats Am J Physiol Gastrointest Liver Physiol, June 1, 2009; 296(6): G1277 - G1286. [Abstract] [Full Text] [PDF]

				G. Tolstanova, T. Khomenko, X. Deng, L. Chen, A. Tarnawski, A. Ahluwalia, S. Szabo, and Z. Sandor Neutralizing Anti-Vascular Endothelial Growth Factor (VEGF) Antibody Reduces Severity of Experimental Ulcerative Colitis in Rats: Direct Evidence for the Pathogenic Role of VEGF J. Pharmacol. Exp. Ther., March 1, 2009; 328(3): 749 - 757. [Abstract] [Full Text] [PDF]